Status:

UNKNOWN

Effect of Intensive Insulin Therapy on Clinical Prognosis of Infants Undergoing Cardiac Surgery

Lead Sponsor:

Xijing Hospital

Conditions:

Cardiac Surgery

Eligibility:

All Genders

Up to 3 years

Phase:

PHASE2

Brief Summary

The investigators sought to determine whether intensive insulin therapy can improve prognosis of infants undergoing cardiac surgery.

Detailed Description

Previous studies showed that tight blood glucose control with insulin during intensive care reduced morbidity and mortality of surgical and medical intensive care patients. Blood sugar control with in...

Eligibility Criteria

Inclusion

  • Infants underwent cardiac surgery with cardiopulmonary bypass

Exclusion

  • Therapy restricted upon admission
  • Preoperative liver or kidney disease or dysfunction
  • Preoperative coagulation disorder
  • Palliative operation or a second operation
  • Type 1 diabetes
  • Type 2 diabetes

Key Trial Info

Start Date :

August 1 2011

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

July 1 2012

Estimated Enrollment :

800 Patients enrolled

Trial Details

Trial ID

NCT01398722

Start Date

August 1 2011

End Date

July 1 2012

Last Update

July 20 2011

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Xijing Hospital

Xi'an, Shaanxi, China, 710032